Brian W. Brady - 30 Jun 2026 Form 4 Insider Report for IZEA Worldwide, Inc. (IZEA)

Reporting relationship: Director
Issuer ticker: IZEA
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 16:03:34 UTC
Prior SEC filing: 01 Apr 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Peter J. Biere as attorney-in-fact for Brian Brady

Key filing fact

Brian W. Brady filed Form 4 for IZEA Worldwide, Inc. (IZEA) on 01 Jul 2026.

Key facts

This page summarizes Brian W. Brady's Form 4 filing for IZEA Worldwide, Inc. (IZEA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 16:03.

Change

Previous filing in this sequence was filed on 01 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001193907 Primary reporting owner

Brady Brian W

Relationship: Director
Address: 1317 EDGEWATER DR #1880, ORLANDO
Signature: By: /s/ Peter J. Biere as attorney-in-fact for Brian Brady
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IZEA transaction

Common Stock

Award

Transaction value
Shares: +4,054
Change %: +0.88%
Price: $0.000000^*
Shares after: 464,773
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

Restricted Stock received for Q2 2026 director fees valued at $15,000 based on the closing market price of $3.70 on the grant date of June 30, 2026. Award vests immediately at the grant date.